Nish Bhat
Angel Investor
San Francisco, United States
Nish Bhat is a seed investor in San Francisco focused on Medical and Health Care. Nish Bhat invests in biotech companies. He was a co-founder of Color before that.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Nish Bhat invests in
Stages Nish Bhat invests in
Countries Nish Bhat invests in
Round sizes
Round size
- Seed
- $2.5M–$16M
Investment Focus
Industry
- Medical 4 (57%)
- Health Care 3 (43%)
- Biotechnology 3 (43%)
- Artificial Intelligence 3 (43%)
- Life Science 2 (29%)
Stage
- Seed 4 (57%)
- Pre-Seed 2 (29%)
- Series A 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine. | $16M / Seed / Jan 03, 2025 | |
|
|
Pioneering the development of AI agents capable of wet lab experimentation. | $2.7M / Pre-Seed / Apr 18, 2024 | |
|
|
Ambience Healthcare develops an AI operating system used for documentation, coding, and clinical workflows in healthcare settings. The company builds an AI medical scribe that captures clinician-patient conversations in real time and converts them into clinical notes. Its scribe tool includes speech recognition, real-time documentation, and AIfeatures designed to integrate with electronic medical record systems. The tool generates notes within seconds and allows customization based on user preferences. | $30M / Series A / Apr 25, 2022 | |
|
|
A community space for musicians of all levels to practice and perform everyday. Backed by angels including cofounders of YouTube, Twitch, and Twitter Spaces. | Seed / Nov 08, 2021 | |
|
|
A community space for musicians of all levels to practice and perform everyday. Backed by angels including cofounders of YouTube, Twitch, and Twitter Spaces. | Pre-Seed / Nov 08, 2021 | |
|
|
Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best. | $7.2M / Seed / Aug 25, 2021 | |
|
|
Adyn is a precision medicine company that develops personalized birth control methods.It provides medically actionable scientific insights and empowers individuals to proactively optimize their health—from birth control to fertility and beyond. The company's first product, the Birth Control Optimization Test, is an at-home kit enabling usersto collect both saliva and finger prick samples to measure hormone baseline levels and aims to assess genetic risk for blood clots and depression. Adyn's technology then synthesizes a medical biography with side effect profiles of estrogens and progestins used in hormonal contraception.Elizabeth Ruzzo headquartered the company in Seattle, Washington in 2019 and is backed by Lux Capital, M13, Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund, and Ascend VC. | $2.5M / Seed / Apr 19, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Nish Bhat invest in?
Nish Bhat invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Nish Bhat's check size?
Nish Bhat typically joins rounds of $2.5M–$16M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Nish Bhat participates in.
When did Nish Bhat last invest?
The most recent investment recorded for Nish Bhat closed in Jan 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!